J. Adamovicz

发表

The use of the PCR to quantitate gene expression.

W. Gause, J. Adamovicz, W. Gause, 1994, PCR methods and applications.

Effective Plague Vaccination via Oral Delivery of Plant Cells Expressing F1-V Antigens in Chloroplasts

Michael L. Singleton, H. Daniell, Yi Ding, 2008, Infection and Immunity.

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).

W. Blackwelder, J. Hartings, T. Brasel, 2010, Vaccine.

Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.

S. Welkos, D. DeShazer, S. Peacock, 2008, Carbohydrate research.

Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection.

F. Finkelman, M. Gately, K. Madden, 1994, Journal of immunology.

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

P. Worsham, A. Krieg, R. Fast, 2009, Vaccine.

Yersinia pestis V Protein Epitopes Recognized by CD4 T Cells

Kiera N. Berggren, M. Parent, J. Adamovicz, 2005, Infection and Immunity.

Modified Caspase-3 Assay Indicates Correlation of Caspase-3 Activity with Immunity of Nonhuman Primates to Yersinia pestis Infection

S. Welkos, J. Adamovicz, S. Norris, 2008, Clinical and Vaccine Immunology.

Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.

G. Lowell, T. Jones, Sonya L. Cyr, 2006, Vaccine.

Evaluation of Imipenem for Prophylaxis and Therapy of Yersinia pestis Delivered by Aerosol in a Mouse Model of Pneumonic Plague

G. Drusano, F. Sörgel, S. Opal, 2014, Antimicrobial Agents and Chemotherapy.

VALIDATION OF QUANTITATIVE ELISAs FOR MEASURING ANTI-YERSINIA PESTIS F1 AND V ANTIBODY CONCENTRATIONS IN NONHUMAN PRIMATE SERA

J. Brown, J. Adamovicz, B. Powell, 2012, Journal of immunoassay & immunochemistry.

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.

S. Welkos, A. Friedlander, G. P. Andrews, 1998, Vaccine.

Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers.

G. D. Ledney, J. Adamovicz, M. M. Moore, 1994, Journal of immunology.

Development of In Vitro Correlate Assays of Immunity to Infection with Yersinia pestis

S. Welkos, J. Bashaw, J. Adamovicz, 2007, Clinical and Vaccine Immunology.

Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens

J. Clements, A. Glynn, C. Roy, 2005, Infection and Immunity.

Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis

S. Welkos, J. K. Pullen, A. Friedlander, 1999, Infection and Immunity.

CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols

D. Waag, H. C. Gelhaus, Mark Smith, 2010, Journal of immune based therapies and vaccines.

Identification of in vivo-induced conserved sequences from Yersinia pestis during experimental plague infection in the rabbit.

R. Ulrich, W. Edwards, G. Vernati, 2010, Vector borne and zoonotic diseases.

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.

J. Adamovicz, S. Little, W. Webster, 2010, Vaccine.

Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.

J. Adamovicz, S. Little, W. Webster, 2008, Biologicals : journal of the International Association of Biological Standardization.

Prevalence of and risk factors associated with ovine progressive pneumonia in Wyoming sheep flocks.

K. Marshall, W. Laegreid, B. Schumaker, 2015, Journal of the American Veterinary Medical Association.

Exogenous Yersinia pestis quorum sensing molecules N-octanoyl-homoserine lactone and N-(3-oxooctanoyl)-homoserine lactone regulate the LcrV virulence factor.

W. Nierman, R. Ulrich, H. C. Gelhaus, 2009, Microbial pathogenesis.

Design and Testing for a Nontagged F1‐V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic Plague

Leonard A. Smith, J. K. Pullen, P. Worsham, 2005, Biotechnology progress.

Antibodies and cytokines independently protect against pneumonic plague.

L. Johnson, M. Parent, J. Adamovicz, 2008, Vaccine.

Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice

V. Patravale, Mostafa F. N. Abushahba, Alexis S. Dadelahi, 2023, Vaccines.

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

T. Hoover, B. Ivins, W. Johnson, 2006, Vaccine.

Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity

T. Hoover, G. P. Andrews, J. Adamovicz, 2007, Proteins.

Toxoplasma gondii seropositivity and the associated risk factors in sheep and pregnant women in El-Minya Governorate, Egypt

A. Abdelbaset, Mostafa F. N. Abushahba, M. Hamed, 2020, Veterinary world.

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

J. Bliska, C. Cote, D. Perlin, 2010, Vaccine.

Flea-Borne Transmission Model To Evaluate Vaccine Efficacy against Naturally Acquired Bubonic Plague

B. J. Hinnebusch, F. Sebbane, Clayton O. Jarrett, 2004, Infection and Immunity.

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model

Sarah L. Keasey, Jennifer L. Dankmeyer, P. Worsham, 2020, Antibodies.

Structural Characterizations of Protein Antigens for The Next-Generation Vaccines Against Anthrax and Plague

J. Adamovicz, W. Ribot, B. Powell, 2004 .